Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2024 · 10-Q
Revenue$53.47M$53.47M−1.5% vs Q3 2023 Net Income$2.12M$2.12M+369.2% vs Q3 2023 EPS Diluted$0.39$0.39+387.5% vs Q3 2023 Gross Profit$33,402,000+1.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$11,535,000+49.5% Free Cash Flowderived$10,407,000+71.6% Margins · derivedGross margin62.5%+2.1 pt vs Q3 2023
Operating margin-0.1%−6.4 pt vs Q3 2023
Net margin4.0%+3.1 pt vs Q3 2023
ended Dec 31, 2023 · filed Feb 5, 2024 · 36 d after period end